BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36577552)

  • 1. Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults - Is There a Difference in Outcome?
    Steinbrecher O; Scharrer A; Raderer M; Brodowicz T; Lamm W
    Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):e256-e262. PubMed ID: 36577552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas.
    Sharma J; Deo SVS; Kumar S; Barwad AW; Rastogi S; Sharma DN; Singh G; Bhoriwal S; Mishra A; K R; Saikia J; Mandal A; Bansal B; Gaur M
    Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):e97-e104. PubMed ID: 38326122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial sarcoma: the importance of size and location for survival.
    Deshmukh R; Mankin HJ; Singer S
    Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial sarcoma of the abdominal wall.
    Fetsch JF; Meis JM
    Cancer; 1993 Jul; 72(2):469-77. PubMed ID: 8391380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
    Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
    Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial sarcoma: Do children do better?
    Smolle MA; Parry M; Jeys L; Abudu S; Grimer R
    Eur J Surg Oncol; 2019 Feb; 45(2):254-260. PubMed ID: 30077520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
    Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
    Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initially localized synovial sarcoma in adults: a retrospective single-center analysis of 26 patients registered at the Department of Oncology, University of Vienna between 2004 and 2013.
    Lamm W; Schur S; Köstler WJ; Amann G; Pokrajac B; Funovics P; Panotopoulos J; Brodowicz T
    Oncology; 2014; 87(1):48-57. PubMed ID: 24969357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic factors and adjuvant treatment effects on survival in adult head and neck synovial cell sarcoma.
    Crowson MG; Lalich I; Keeney MG; Garcia JJ; Price DL
    Head Neck; 2015 Mar; 37(3):375-80. PubMed ID: 24430934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy.
    Okcu MF; Despa S; Choroszy M; Berrak SG; Cangir A; Jaffe N; Raney RB
    Med Pediatr Oncol; 2001 Aug; 37(2):90-6. PubMed ID: 11496345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age as an independent prognostic factor for survival of localised synovial sarcoma patients.
    Vlenterie M; Ho VK; Kaal SE; Vlenterie R; Haas R; van der Graaf WT
    Br J Cancer; 2015 Dec; 113(11):1602-6. PubMed ID: 26554650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma.
    Charbonneau B; Vogel RI; Manivel JC; Rizzardi A; Schmechel SC; Ognjanovic S; Subramanian S; Largaespada D; Weigel B
    Hum Pathol; 2013 Sep; 44(9):1918-26. PubMed ID: 23664540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of conditional treatment effects of adjuvant treatments on patients with synovial sarcoma using Bayesian subgroup analysis.
    Seo SW; Kim J; Son J; Lim S
    BMC Med Inform Decis Mak; 2020 Dec; 20(1):320. PubMed ID: 33272256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial sarcoma: identification of low and high risk groups.
    Bergh P; Meis-Kindblom JM; Gherlinzoni F; Berlin O; Bacchini P; Bertoni F; Gunterberg B; Kindblom LG
    Cancer; 1999 Jun; 85(12):2596-607. PubMed ID: 10375108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.
    Stanelle EJ; Christison-Lagay ER; Healey JH; Singer S; Meyers PA; La Quaglia MP
    Ann Surg Oncol; 2013 Jan; 20(1):73-9. PubMed ID: 22878620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register.
    Papworth KE; Arroyo VM; Styring E; Zaikova O; Melin BS; Lupo PJ
    Cancer; 2019 Oct; 125(20):3595-3602. PubMed ID: 31287163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.